Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Jorge A Valdes. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Jorge A Valdes har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:DXCM / DexCom, Inc. | CTO | 10 442 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Jorge A Valdes. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Jorge A Valdes som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −14 400 | 10 442 | −57,97 | 77,74 | −1 119 514 | 811 803 |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −3 964 | 24 842 | −13,76 | 77,55 | −307 411 | 1 926 512 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 694 | 28 806 | −18,86 | 77,55 | −519 124 | 2 233 923 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 12 667 | 35 500 | 55,48 | 78,24 | 991 066 | 2 777 520 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 7 500 | 22 833 | 48,91 | 78,24 | 586 800 | 1 786 454 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 11 834 | 15 333 | 338,21 | 78,24 | 925 892 | 1 199 654 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 254 | 34 079 | −15,51 | 77,55 | −485 001 | 2 642 847 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −12 667 | 40 333 | −23,90 | 78,24 | −991 066 | 3 155 654 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −7 500 | 53 000 | −12,40 | 78,24 | −586 800 | 4 146 720 | |
2017-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −11 834 | 60 500 | −16,36 | 78,24 | −925 892 | 4 733 520 | |
2017-02-13 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 000 | 0 | −100,00 | 79,76 | −558 316 | ||
2017-02-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 000 | 72 334 | −8,82 | 79,76 | −558 316 | 5 769 316 |
2017-02-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 000 | 79 334 | 9,68 | 9,80 | 68 600 | 777 473 | |
2017-02-03 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −13 900 | 7 000 | −66,51 | 80,00 | −1 112 000 | 560 000 | |
2017-02-03 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −13 900 | 72 334 | −16,12 | 80,00 | −1 112 000 | 5 786 720 |
2017-02-03 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 13 900 | 86 234 | 19,22 | 9,80 | 136 220 | 845 093 | |
2017-01-18 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −7 173 | 20 900 | −25,55 | 80,00 | −573 840 | 1 672 000 | |
2017-01-18 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −8 927 | 0 | −100,00 | 80,00 | −714 160 | ||
2017-01-18 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | 80,00 | −800 000 | ||
2017-01-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 173 | 72 334 | −9,02 | 80,00 | −573 840 | 5 786 720 |
2017-01-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 173 | 79 507 | 9,92 | 9,80 | 70 295 | 779 169 | |
2017-01-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 72 334 | −12,15 | 80,00 | −800 000 | 5 786 720 |
2017-01-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 82 334 | 13,82 | 7,63 | 76 300 | 628 208 | |
2017-01-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −8 927 | 72 334 | −10,99 | 80,00 | −714 160 | 5 786 720 |
2017-01-18 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 8 927 | 81 261 | 12,34 | 9,80 | 87 485 | 796 358 | |
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −900 | 100 | −90,00 | 63,00 | −56 700 | 6 300 | |
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −2 583 | 0 | −100,00 | 62,83 | −162 288 | ||
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −7 000 | 0 | −100,00 | 63,02 | −441 162 | ||
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −417 | 10 000 | −4,00 | 63,49 | −26 474 | 634 875 | |
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 583 | 72 334 | −3,45 | 62,83 | −162 288 | 4 544 680 |
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 2 583 | 74 917 | 3,57 | 7,63 | 19 708 | 571 617 | |
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −900 | 72 334 | −1,23 | 63,31 | −56 981 | 4 579 596 |
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 900 | 73 234 | 1,24 | 3,19 | 2 871 | 233 616 | |
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −417 | 72 334 | −0,57 | 63,49 | −26 474 | 4 592 305 |
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 417 | 72 751 | 0,58 | 7,63 | 3 182 | 555 090 | |
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 000 | 72 334 | −8,82 | 63,02 | −441 162 | 4 558 720 |
2017-01-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 000 | 79 334 | 9,68 | 7,79 | 54 530 | 618 012 | |
2016-12-13 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 925 | 0 | −100,00 | 64,81 | −254 371 | ||
2016-12-13 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −2 637 | 7 000 | −27,36 | 64,81 | −170 898 | 453 655 | |
2016-12-13 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −3 438 | 0 | −100,00 | 64,81 | −222 810 | ||
2016-12-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 925 | 72 334 | −5,15 | 64,81 | −254 371 | 4 687 815 |
2016-12-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 3 925 | 76 259 | 5,43 | 7,79 | 30 576 | 594 058 | |
2016-12-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 438 | 72 334 | −4,54 | 64,81 | −222 810 | 4 687 815 |
2016-12-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 3 438 | 75 772 | 4,75 | 7,25 | 24 926 | 549 347 | |
2016-12-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 637 | 72 334 | −3,52 | 64,81 | −170 898 | 4 687 815 |
2016-12-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 2 637 | 74 971 | 3,65 | 7,79 | 20 542 | 584 024 | |
2016-10-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −11 000 | 2 583 | −80,98 | 84,42 | −928 579 | 218 047 | |
2016-10-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −11 000 | 72 334 | −13,20 | 84,42 | −928 579 | 6 106 169 |
2016-10-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 11 000 | 83 334 | 15,21 | 7,63 | 83 930 | 635 838 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −7 071 | 3 499 | −66,90 | 92,06 | −650 965 | 322 122 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −12 000 | 13 583 | −46,91 | 93,66 | −1 123 909 | 1 272 172 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 001 | 10 570 | −27,46 | 93,72 | −374 984 | 990 648 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 312 | 14 571 | −30,23 | 93,72 | −591 578 | 1 365 633 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 7 500 | 20 883 | 56,04 | 95,80 | 718 500 | 2 000 591 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 11 833 | 13 383 | 763,42 | 95,80 | 1 133 601 | 1 282 091 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −7 500 | 72 334 | −9,39 | 95,80 | −718 500 | 6 929 597 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −11 833 | 79 834 | −12,91 | 95,80 | −1 133 601 | 7 648 097 | |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −12 000 | 91 667 | −11,58 | 93,66 | −1 123 909 | 8 585 449 |
2016-09-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 12 000 | 103 667 | 13,09 | 7,63 | 91 560 | 790 979 | |
2016-08-11 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −32 000 | 25 583 | −55,57 | 91,06 | −2 913 978 | 2 329 634 | |
2016-08-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −32 000 | 91 667 | −25,88 | 91,06 | −2 913 978 | 8 347 362 |
2016-08-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 32 000 | 123 667 | 34,91 | 7,63 | 244 160 | 943 579 | |
2016-08-09 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −25 000 | 28 073 | −47,10 | 91,22 | −2 280 375 | 2 560 679 | |
2016-08-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −25 000 | 91 667 | −21,43 | 91,22 | −2 280 375 | 8 361 405 | |
2016-08-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 25 000 | 116 667 | 27,27 | 9,80 | 245 000 | 1 143 337 | |
2016-07-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −32 000 | 57 583 | −35,72 | 79,36 | −2 539 565 | 4 569 867 | |
2016-07-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −32 000 | 91 667 | −25,88 | 79,36 | −2 539 565 | 7 274 821 |
2016-07-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 32 000 | 123 667 | 34,91 | 7,63 | 244 160 | 943 579 | |
2016-06-10 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −10 000 | 3 925 | −71,81 | 73,71 | −737 147 | 289 330 | |
2016-06-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 91 667 | −9,84 | 73,71 | −737 147 | 6 757 205 |
2016-06-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 10 000 | 101 667 | 10,91 | 7,79 | 77 900 | 791 986 | |
2016-06-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −8 038 | 1 550 | −83,83 | 70,00 | −562 660 | 108 500 |
2016-05-19 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −20 000 | 53 073 | −27,37 | 61,75 | −1 234 944 | 3 277 109 | |
2016-05-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −20 000 | 91 667 | −17,91 | 61,75 | −1 234 944 | 5 660 181 | |
2016-05-19 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 20 000 | 111 667 | 21,82 | 9,80 | 196 000 | 1 094 337 | |
2016-04-28 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −10 000 | 9 588 | −51,05 | 70,00 | −700 000 | 671 160 |
2016-04-05 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −20 000 | 13 925 | −58,95 | 70,08 | −1 401 586 | 975 854 | |
2016-04-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −20 000 | 91 667 | −17,91 | 70,08 | −1 401 586 | 6 423 959 |
2016-04-05 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 20 000 | 111 667 | 21,82 | 7,79 | 155 800 | 869 886 | |
2016-03-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 345 | 19 588 | −24,47 | 63,96 | −405 834 | 1 252 872 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 11 937 | 25 933 | 85,29 | 65,15 | 777 696 | 1 689 535 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −11 937 | 91 667 | −11,52 | 65,15 | −777 696 | 5 972 105 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −8 133 | 13 996 | −36,75 | 63,18 | −513 843 | 884 267 | |
2016-03-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −4 725 | 22 129 | −17,60 | 63,18 | −298 526 | 1 398 110 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 15 000 | 26 854 | 126,54 | 66,10 | 991 500 | 1 775 049 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 11 833 | 11 854 | 56 347,62 | 66,10 | 782 161 | 783 549 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −15 000 | 103 604 | −12,65 | 66,10 | −991 500 | 6 848 224 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −11 833 | 118 604 | −9,07 | 66,10 | −782 161 | 7 839 724 | |
2016-03-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 38 000 | 130 437 | 41,11 | 0,00 | 38 | 130 | |
2016-01-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −5 610 | 21 | −99,63 | 80,16 | −449 723 | 1 683 |
2016-01-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 641 | 5 631 | −22,57 | 78,43 | −128 709 | 441 659 |
2015-12-10 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −6 438 | 33 925 | −15,95 | 86,12 | −554 457 | 2 921 709 | |
2015-12-10 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −3 562 | 0 | −100,00 | 85,04 | −302 906 | ||
2015-12-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −6 438 | 92 437 | −6,51 | 86,12 | −554 457 | 7 960 915 |
2015-12-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 6 438 | 98 875 | 6,96 | 7,79 | 50 152 | 770 236 | |
2015-12-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −3 562 | 92 437 | −3,71 | 85,04 | −302 906 | 7 860 667 |
2015-12-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 3 562 | 95 999 | 3,85 | 7,25 | 25 824 | 695 993 | |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −30 000 | 40 363 | −42,64 | 83,86 | −2 515 794 | 3 384 833 | |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −10 500 | 7 272 | −59,08 | 83,36 | −875 303 | 606 210 | |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −30 000 | 92 437 | −24,50 | 83,86 | −2 515 794 | 7 751 748 | |
2015-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 30 000 | 122 437 | 32,45 | 7,79 | 233 700 | 953 784 | |
2015-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 325 | 17 772 | −26,25 | 95,93 | −606 774 | 1 704 914 | |
2015-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 11 937 | 24 097 | 98,17 | 97,41 | 1 162 783 | 2 347 289 | |
2015-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −11 937 | 92 437 | −11,44 | 97,41 | −1 162 783 | 9 004 288 | |
2015-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 253 | 12 160 | −33,96 | 90,90 | −568 388 | 1 105 326 | |
2015-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 11 833 | 18 413 | 179,83 | 91,05 | 1 077 395 | 1 676 504 | |
2015-09-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −11 833 | 104 374 | −10,18 | 91,05 | −1 077 395 | 9 503 253 | |
2015-09-03 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −20 000 | 70 363 | −22,13 | 91,22 | −1 824 400 | 6 418 513 | |
2015-09-03 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −20 000 | 116 207 | −14,68 | 91,22 | −1 824 400 | 10 600 403 | |
2015-09-03 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 20 000 | 136 207 | 17,21 | 7,79 | 155 800 | 1 061 053 | |
2015-07-09 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −42 461 | 0 | −100,00 | 79,75 | −3 386 091 | ||
2015-07-09 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −7 539 | 0 | −100,00 | 80,34 | −605 656 | ||
2015-07-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −42 461 | 116 207 | −26,76 | 79,75 | −3 386 091 | 9 267 032 |
2015-07-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 42 461 | 158 668 | 36,54 | 10,48 | 444 991 | 1 662 841 | |
2015-07-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −7 539 | 116 207 | −6,09 | 80,34 | −605 656 | 9 335 652 |
2015-07-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 7 539 | 123 746 | 6,49 | 10,48 | 79 009 | 1 296 858 | |
2015-06-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −11 437 | 6 580 | −63,48 | 70,79 | −809 590 | 465 778 |
2015-06-10 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 243 | 0 | −100,00 | 72,07 | −594 085 | ||
2015-06-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −8 243 | 116 207 | −6,62 | 72,07 | −594 085 | 8 375 201 |
2015-06-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 8 243 | 124 450 | 7,09 | 13,45 | 110 868 | 1 673 852 | |
2015-05-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −11 194 | 18 017 | −38,32 | 68,41 | −765 775 | 1 232 532 | |
2015-05-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −11 440 | 29 211 | −28,14 | 67,97 | −777 562 | 1 985 434 |
2015-05-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 244 | 8 243 | −50,00 | 68,51 | −564 791 | 564 722 | |
2015-05-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −8 244 | 116 207 | −6,62 | 68,51 | −564 791 | 7 961 260 |
2015-05-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 8 244 | 124 451 | 7,09 | 13,45 | 110 882 | 1 673 866 | |
2015-04-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −11 440 | 40 651 | −21,96 | 64,78 | −741 126 | 2 633 522 |
2015-04-10 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 244 | 16 487 | −33,33 | 63,81 | −526 048 | 1 052 032 | |
2015-04-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −8 244 | 116 207 | −6,62 | 63,81 | −526 048 | 7 415 145 |
2015-04-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 8 244 | 124 451 | 7,09 | 13,45 | 110 882 | 1 673 866 | |
2015-03-24 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −27 100 | 52 091 | −34,22 | 62,32 | −1 688 872 | 3 246 311 |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −11 138 | 79 191 | −12,33 | 59,78 | −665 833 | 4 734 062 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 371 | 90 329 | −6,59 | 58,58 | −373 191 | 5 291 157 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 11 937 | 96 700 | 14,08 | 59,91 | 715 146 | 5 793 297 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −12 529 | 84 763 | −12,88 | 58,74 | −735 956 | 4 978 996 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −5 357 | 97 292 | −5,22 | 58,74 | −314 671 | 5 714 952 | |
2015-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −11 937 | 116 207 | −9,32 | 59,91 | −715 146 | 6 961 961 | |
2015-03-11 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 244 | 24 731 | −25,00 | 58,77 | −484 529 | 1 453 527 | |
2015-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −926 | 102 649 | −0,89 | 59,87 | −55 440 | 6 145 596 |
2015-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −5 712 | 103 575 | −5,23 | 59,24 | −338 405 | 6 136 259 | |
2015-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −8 244 | 128 144 | −6,04 | 58,77 | −484 529 | 7 531 471 |
2015-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 8 244 | 136 388 | 6,43 | 13,45 | 110 882 | 1 834 419 | |
2015-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 23 667 | 109 287 | 27,64 | 59,59 | 1 410 317 | 6 512 412 | |
2015-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 11 937 | 85 620 | 16,20 | 59,59 | 711 326 | 5 102 096 | |
2015-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −23 667 | 128 144 | −15,59 | 59,59 | −1 410 317 | 7 636 101 | |
2015-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −11 937 | 151 811 | −7,29 | 59,59 | −711 326 | 9 046 417 | |
2015-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 45 000 | 163 748 | 37,90 | 0,00 | 45 | 164 | |
2015-02-11 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −8 244 | 32 975 | −20,00 | 61,67 | −508 380 | 2 033 459 | |
2015-02-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −926 | 73 683 | −1,24 | 61,67 | −57 103 | 4 543 787 |
2015-02-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −8 244 | 118 748 | −6,49 | 61,67 | −508 380 | 7 322 797 |
2015-02-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 8 244 | 126 992 | 6,94 | 13,45 | 110 882 | 1 708 042 | |
2015-01-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −926 | 74 609 | −1,23 | 58,53 | −54 199 | 4 366 865 |
2015-01-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −4 045 | 41 219 | −8,94 | 57,44 | −232 325 | 2 367 413 | |
2015-01-12 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −1 563 | 0 | −100,00 | 57,44 | −89 771 | ||
2015-01-12 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −2 636 | 1 563 | −62,78 | 57,44 | −151 399 | 89 771 | |
2015-01-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −1 563 | 118 748 | −1,30 | 57,44 | −89 771 | 6 820 291 |
2015-01-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 1 563 | 120 311 | 1,32 | 13,45 | 21 022 | 1 618 183 | |
2015-01-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −2 636 | 118 748 | −2,17 | 57,44 | −151 399 | 6 820 291 |
2015-01-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 2 636 | 121 384 | 2,22 | 13,45 | 35 454 | 1 632 615 | |
2015-01-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −4 045 | 118 748 | −3,29 | 57,44 | −232 325 | 6 820 291 |
2015-01-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 4 045 | 122 793 | 3,41 | 13,45 | 54 405 | 1 651 566 | |
2014-12-10 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 3 562 | −81,79 | 56,03 | −896 509 | 199 585 | |
2014-12-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 118 748 | −11,87 | 56,03 | −896 509 | 6 653 664 |
2014-12-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 134 748 | 13,47 | 7,25 | 116 000 | 976 923 | |
2014-11-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 19 562 | −44,99 | 51,23 | −819 706 | 1 002 193 | |
2014-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 118 748 | −11,87 | 51,23 | −819 706 | 6 083 650 |
2014-11-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 134 748 | 13,47 | 7,25 | 116 000 | 976 923 | |
2014-10-10 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 35 562 | −31,03 | 40,29 | −644 651 | 1 432 818 | |
2014-10-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 118 748 | −11,87 | 40,29 | −644 651 | 4 784 440 |
2014-10-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 134 748 | 13,47 | 7,25 | 116 000 | 976 923 | |
2014-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 11 936 | 75 535 | 18,77 | 43,36 | 517 574 | 3 275 379 | |
2014-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 308 | 63 599 | −9,02 | 43,36 | −273 530 | 2 757 805 | |
2014-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −11 936 | 118 748 | −9,13 | 43,36 | −517 574 | 5 149 198 | |
2014-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | 11 937 | 69 907 | 20,59 | 43,23 | 516 062 | 3 022 226 | |
2014-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 225 | 57 970 | −9,70 | 43,23 | −269 120 | 2 506 165 | |
2014-09-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
J - Other | −11 937 | 130 684 | −8,37 | 43,23 | −516 062 | 5 649 744 | |
2014-09-10 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 1 000 | −94,12 | 42,98 | −687 736 | 42 984 | |
2014-09-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 142 621 | −10,09 | 42,98 | −687 736 | 6 130 350 |
2014-09-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 158 621 | 11,22 | 3,19 | 51 040 | 506 001 | |
2014-08-25 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −10 671 | 64 195 | −14,25 | 43,58 | −465 040 | 2 797 605 | |
2014-08-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 17 000 | −48,48 | 43,56 | −697 006 | 740 569 | |
2014-08-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 217 487 | −6,85 | 43,56 | −697 006 | 9 474 364 |
2014-08-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 233 487 | 7,36 | 3,19 | 51 040 | 744 824 | |
2014-07-09 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 33 000 | −32,65 | 36,66 | −586 506 | 1 209 668 | |
2014-07-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 217 487 | −6,85 | 36,66 | −586 506 | 7 972 334 |
2014-07-09 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 233 487 | 7,36 | 3,19 | 51 040 | 744 824 | |
2014-06-11 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 49 000 | −24,62 | 36,68 | −586 866 | 1 797 276 | |
2014-06-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 217 487 | −6,85 | 36,68 | −586 866 | 7 977 227 |
2014-06-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 233 487 | 7,36 | 3,19 | 51 040 | 744 824 | |
2014-05-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 65 000 | −19,75 | 29,83 | −477 331 | 1 939 158 | |
2014-05-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 217 487 | −6,85 | 29,83 | −477 331 | 6 488 333 |
2014-05-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 233 487 | 7,36 | 3,19 | 51 040 | 744 824 | |
2014-04-10 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 81 000 | −16,49 | 35,99 | −575 898 | 2 915 482 | |
2014-04-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 217 487 | −6,85 | 35,99 | −575 898 | 7 828 140 |
2014-04-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 233 487 | 7,36 | 3,19 | 51 040 | 744 824 | |
2014-03-20 |
|
4 | DXCM |
DEXCOM INC
Incentive Stock Option (right to buy) |
M - Exercise | −27 100 | 4 199 | −86,58 | 47,42 | −1 285 082 | 199 117 | |
2014-03-20 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 27 100 | 217 487 | 14,23 | 13,45 | 364 495 | 2 925 200 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −23 437 | 45 264 | −34,11 | 46,18 | −1 082 328 | 2 090 305 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −12 616 | 190 387 | −6,21 | 45,22 | −570 516 | 8 609 605 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −23 437 | 203 003 | −10,35 | 46,18 | −1 082 328 | 9 374 739 | |
2014-03-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 23 437 | 226 440 | 11,55 | 13,45 | 315 228 | 3 045 618 | |
2014-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −12 850 | 203 003 | −5,95 | 46,10 | −592 403 | 9 358 723 | |
2014-03-11 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 97 000 | −14,16 | 46,57 | −745 120 | 4 517 290 | |
2014-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 215 853 | −6,90 | 46,57 | −745 120 | 10 052 274 |
2014-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 231 853 | 7,41 | 3,19 | 51 040 | 739 611 | |
2014-03-11 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 71 000 | 215 853 | 49,02 | 0,00 | 71 | 216 | |
2014-02-12 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 113 000 | −12,40 | 38,03 | −608 488 | 4 297 446 | |
2014-02-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 144 853 | −9,95 | 38,03 | −608 488 | 5 508 832 |
2014-02-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 160 853 | 11,05 | 3,19 | 51 040 | 513 121 | |
2014-01-10 |
|
4 | DXCM |
DEXCOM INC
Non-Qualified Stock Option (right to buy) |
M - Exercise | −16 000 | 129 000 | −11,03 | 35,36 | −565 725 | 4 561 156 | |
2014-01-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | X | −16 000 | 144 853 | −9,95 | 35,36 | −565 725 | 5 121 683 |
2014-01-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
M - Exercise | 16 000 | 160 853 | 11,05 | 3,19 | 51 040 | 513 121 | |
2013-11-13 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −26 600 | 144 853 | −15,51 | 33,34 | −886 932 | 4 829 877 | |
2013-09-10 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −11 790 | 171 453 | −6,43 | 26,89 | −317 026 | 4 610 268 | |
2013-06-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −1 992 | 183 243 | −1,08 | 22,03 | −43 886 | 4 037 027 | |
2013-03-15 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −15 655 | 185 235 | −7,79 | 15,69 | −245 627 | 2 906 337 | |
2013-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −21 054 | 200 890 | −9,49 | 16,31 | −343 424 | 3 276 837 | |
2013-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 71 621 | 221 944 | 47,64 | 0,00 | 72 | 222 | |
2013-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −2 000 | 150 323 | −1,31 | 15,58 | −31 162 | 2 342 183 | |
2013-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −1 000 | 152 323 | −0,65 | 15,61 | −15 610 | 2 377 762 | |
2012-12-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −22 939 | 0 | −100,00 | 14,00 | −321 146 | ||
2012-12-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −4 811 | 22 939 | −17,34 | 14,10 | −67 835 | 323 440 | |
2012-12-14 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
S - Sale | −4 122 | 27 750 | −12,93 | 14,29 | −58 913 | 396 611 | |
2012-09-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −6 417 | 153 323 | −4,02 | 13,68 | −87 763 | 2 096 937 | |
2012-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −8 781 | 159 740 | −5,21 | 10,26 | −90 078 | 1 638 661 | |
2012-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
D - Sale to Issuer | −5 971 | 168 521 | −3,42 | 10,26 | −61 252 | 1 728 739 | |
2012-03-12 |
|
4 | DXCM |
DEXCOM INC
Common Stock |
A - Award | 71 621 | 174 492 | 69,62 | 0,00 | 72 | 174 |